國家衛生研究院 NHRI:Item 3990099045/12509
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 915063      線上人數 : 1404
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12509


    題名: Effects of different mechanisms on antimicrobial resistance in Acinetobacter baumannii: A strategic system for the screening and activity testing of new antibiotics
    作者: Tsai, YK;Liou, CH;Lin, JC;Fung, CP;Chang, FY;Siu, LK
    貢獻者: National Institute of Infectious Diseases and Vaccinology
    摘要: A total of 50 engineered strains with various resistance mechanisms from two fully susceptible strains, Acinetobacter baumannii KAB1544 and ATCC 17978, were constructed by in-frame deletion, site-directed mutagenesis and plasmid transformation. These strains included 31 strains with chromosome-mediated resistance and 19 strains with plasmid-mediated resistance, and each of the 50 resistance mechanisms showed similar effects on the MICs for KAB1544 and ATCC 17978. Compared to the parental strains, the engineered strains related to some efflux pumps showed a significant (>/=4-fold) difference in the MICs of beta-lactams, quinolones, aminoglycosides, tetracyclines, folate pathway inhibitors and/or phenicols, while no significant (>/=4-fold) effects on the MICs were found for the engineered strains lacking OmpA, CarO, Omp25, Omp33, OmpW or OprD. Mechanisms due to GyrA/ParC mutations, beta-lactamase, aminoglycoside-modifying enzyme, 16S rRNA methylase and tet resistance gene contributed their corresponding resistance, as previously published. In conclusion, strains constructed in this study have clear resistance mechanisms and can be used to screen and assess compounds against specific resistance mechanisms for treating Acinetobacter. In addition to our previously published system for Enterobacteriaceae, the combination of these two systems could increase the coverage of bacterial types for drug assessment and facilitate the selection process of new candidates in the drug development against superbugs.
    日期: 2020-04
    關聯: International Journal of Antimicrobial Agents. 2020 Apr;55(4):Article number 105918.
    Link to: http://dx.doi.org/10.1016/j.ijantimicag.2020.105918
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0924-8579&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000529330100013
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85082513967
    顯示於類別:[蕭樑基] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB32007593.pdf699KbAdobe PDF181檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋